BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 927164)

  • 1. Spironolactone-induced inhibition of aldosterone biosynthesis in primary aldosteronism: morphological and functional studies.
    Conn JW; Hinerman DL
    Metabolism; 1977 Dec; 26(12):1293-307. PubMed ID: 927164
    [No Abstract]   [Full Text] [Related]  

  • 2. [Spironolactone bodies. Light and electron microscope study apropos of 4 cases of adrenal adenomas with primary hyperaldosteronism].
    Vacher-Lavenu MC; Lellouch-Tubiana A; Louvel A; Daudet-Monsac M; Abelanet R
    Ann Pathol; 1982; 2(4):311-9. PubMed ID: 6297519
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Biosynthesis of aldosterone and 11-desoxycorticosterone in the adrenal gland and in adenoma in a patient with primary hyperaldosteronism].
    Dahm K; Breuer H; Bayer JM
    Acta Endocrinol (Copenh); 1969 Nov; 62(3):425-37. PubMed ID: 5395008
    [No Abstract]   [Full Text] [Related]  

  • 4. Twenty-four year spironolactone therapy in an aged patient with aldosterone-producing adenoma.
    Takeda R; Yamazaki T; Ito Y; Koshida H; Morise T; Miyamori I; Hashimoto T; Morimoto S
    Acta Endocrinol (Copenh); 1992 Feb; 126(2):186-90. PubMed ID: 1311894
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ultrastructural studies of adrenal adenoma causing primary aldosteronism.
    Kuramoto H; Kumazawa J
    Virchows Arch A Pathol Anat Histopathol; 1985; 407(3):271-8. PubMed ID: 2994287
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reduced aldosterone secretion during spironolactone treatment in primary aldosteronism: report of a case.
    Sundsfjord JA; Marton P; Jorgensen H; Aakvaag A
    J Clin Endocrinol Metab; 1974 Oct; 39(4):734-9. PubMed ID: 4370321
    [No Abstract]   [Full Text] [Related]  

  • 7. Ultrastructural and biochemical studies in human adrenocortical adenomas associated with primary aldosteronism.
    Murakoshi M; Osamura Y; Watanabe K; Nomoto Y; Sakai H
    Tokai J Exp Clin Med; 1983 Nov; 8(4):375-83. PubMed ID: 6679942
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Studies on the biosynthesis of aldosterone in solitary adenoma and in nodular hyperplasia of the adrenal cortex in patients exhibiting Conn's syndrome.
    Vecsei P; Purjesz I; Wolff HP
    Acta Endocrinol (Copenh); 1969 Nov; 62(3):391-8. PubMed ID: 5395005
    [No Abstract]   [Full Text] [Related]  

  • 9. [Clinical characteristics of primary and secondary aldosteronism].
    Nishikawa T; Saito J
    Nihon Rinsho; 2006 May; Suppl 1():621-3. PubMed ID: 16776232
    [No Abstract]   [Full Text] [Related]  

  • 10. In vitro responses of aldosterone-producing adenomas to angiotensin II and ACTH after treatment with spironolactone before adrenalectomy.
    Wisgerhof M
    J Lab Clin Med; 1984 Aug; 104(2):160-5. PubMed ID: 6086794
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Spironolactone bodies in an adrenal adenoma.
    Shrago SS; Waisman J; Cooper PH
    Arch Pathol; 1975 Aug; 99(8):416-20. PubMed ID: 167703
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Studies of impaired aldosterone response to spironolactone-induced renin and potassium elevations in adenomatous but not hyperplastic primary aldosteronism.
    Kater CE; Biglieri EG; Schambelan M; Arteaga E
    Hypertension; 1983; 5(6 Pt 3):V115-21. PubMed ID: 6360878
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alterations of calcium metabolism and of parathyroid function in primary aldosteronism, and their reversal by spironolactone or by surgical removal of aldosterone-producing adenomas.
    Rossi E; Sani C; Perazzoli F; Casoli MC; Negro A; Dotti C
    Am J Hypertens; 1995 Sep; 8(9):884-93. PubMed ID: 8541003
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pitfalls in the surgery of aldosterone-producing tumors.
    Ackerman NB; Johnson-Giannopoulos N; Winer N
    Am J Surg; 1972 Dec; 124(6):774-6. PubMed ID: 4635221
    [No Abstract]   [Full Text] [Related]  

  • 15. Primary aldosteronism with normal aldosterone levels in blood and urine.
    Nomura K; Han DC; Jibiki K; Demura H; Tsushima T; Shizume K
    Acta Endocrinol (Copenh); 1985 Dec; 110(4):522-5. PubMed ID: 4090913
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adrenal scintigraphy in primary aldosteronism caused by an aldosterone producing adenoma.
    Lund JO; Elmgreen J; Gammelgaard PA; Hansner E
    Scand J Urol Nephrol; 1980; 14(3):292-6. PubMed ID: 7209437
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Primary aldosteronism.
    McGuffin WL; Gunnells JC
    Urol Clin North Am; 1977 Jun; 4(2):227-37. PubMed ID: 331615
    [No Abstract]   [Full Text] [Related]  

  • 18. Control of plasma aldosterone in a patient with Conn's syndrome before and during spironolactone medication.
    Vetter H; Vetter W
    Klin Wochenschr; 1975 Apr; 53(8):391-3. PubMed ID: 211313
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activation of aldosterone secretion in primary aldosteronism.
    Spark RF; Dale SL; Kahn PC; Melby JC
    J Clin Invest; 1969 Jan; 48(1):96-104. PubMed ID: 4303791
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Medical management of aldosterone-producing adenomas.
    Ferriss JB
    Ann Intern Med; 2000 Apr; 132(7):593-4; author reply 594. PubMed ID: 10744603
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.